Essa PharmaEPIX
13F holders, Q3 2024 (September 30)32holders +1
4new positions
3sold out
2famous investors
$6.06avg. 13F price*
At the end of Q3 2024, 32 institutions reported holding Essa Pharma Inc. (EPIX) in their 13F filings, up 1 from Q2 2024. 4 opened new positions and 3 sold out. The largest holders were BVF Inc. ($53.0M), Bellevue Group AG ($47.8M) and Soleus Capital Management, L.P. ($26.0M). 2 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Essa Pharma Inc.
- CUSIP
- 29668H708
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $207K |
| Exits | 3 | $5.2M |
All 13F filers, Q2 2024 → Q3 2024: 1,190,164 shares bought and 1,295,502 shares sold, net −105,338 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| BVF Inc. | 1.55% | No change | 8,748,629 | $53.0M |
| Bellevue Group AG | 0.77% | Reduce -0.1% | 7,879,583 | $47.8M |
| Soleus Capital Management, L.P. | 2.16% | Add +1.8% | 4,288,167 | $26.0M |
| Morgan Stanley | 0.00% | Add +0.1% | 4,181,342 | $25.3M |
| RTW Investments, LP | 0.29% | Add +41.9% | 3,261,496 | $19.8M |
| PFM Health Sciences, LP | 0.97% | Reduce -7.5% | 2,742,936 | $16.6M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | No change | 1,474,165 | $8.9M |
| Rhenman & Partners Asset Management AB | 0.40% | Reduce -0.2% | 804,649 | $4.9M |
| Rock Springs Capital Management LP | 0.13% | No change | 677,005 | $4.1M |
| Parkman Healthcare Partners LLC | 0.27% | Add +37.2% | 345,902 | $2.1M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -11.9% | 278,000 | $1.7M |
| Cibc World Market Inc. | 0.00% | Reduce -8.3% | 73,587 | $446K |
| D. E. Shaw & Co. | 0.00% | Reduce -0.8% | 62,955 | $382K |
| American Century Companies Inc. | 0.00% | Reduce -0.2% | 46,652 | $283K |
| BNP Paribas Financial Markets | 0.00% | Add +2.1% | 44,495 | $270K |
| Kennedy Capital Management LLC | 0.01% | Add +19.2% | 41,092 | $249K |
| Royal Bank of Canada | 0.00% | Add +12.3% | 40,797 | $248K |
| Citadel Advisors | 0.00% | Add +13.3% | 28,479 | $173K |
| Group One Trading LLC | 0.01% | New | 27,795 | $168K |
| Geode Capital Management, LLC | 0.00% | No change | 26,858 | $163K |
| Osaic Holdings, Inc. | 0.00% | No change | 6,000 | $36K |
| BlackRock, Inc. | 0.00% | — | 5,609 | $34K |
| Simplex Trading, LLC | 0.00% | New | 5,162 | $31K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +97.6% | 4,050 | $25K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 2,500 | $15K |
| UBS Group AG | 0.00% | Add +54.4% | 2,417 | $15K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 900 | $5K |
| Truvestments Capital LLC | 0.00% | New | 846 | $5K |
| Laurel Wealth Advisors LLC | 0.00% | No change | 600 | $4K |
| Barclays PLC | 0.00% | New | 355 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 21 | $127 |
| Bank of America Corp. | 0.00% | No change | 8 | $48 |
"% of holder's portfolio" is EPIX's weight in each manager's 13F, not the share of Essa Pharma Inc. the manager owns.